Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 156 entries
View as:

Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT05217485 Org: User:
Start: 03/31/22 End: 03/31/24 Due: 03/31/25

Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03150576 Org: User:
Start: 05/31/16 End: 06/30/34 Due: 06/30/35

Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02265809 Org: User:
Start: 10/03/14 End: 05/26/16 Due: 05/26/17

PDE3B in Metabolic Regulation

Phase: N/A Priority: Normal
NCT ID: NCT06533007 Org: User:
Start: 09/30/24 End: 09/30/29 Due: 09/30/30

Bimodal, CROS and Severe Profound Hearing Loss Study

Phase: N/A Priority: Normal
NCT ID: NCT04222296 Org: User:
Start: 09/04/18 End: 03/01/21 Due: 03/01/22

Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00978549 Org: User:
Start: 04/30/08 End: 10/31/10 Due: 10/31/11

Trial of a Breathlessness Intervention Service for Intractable Breathlessness

Phase: N/A Priority: Normal
NCT ID: NCT00678405 Org: User:
Start: 08/31/08 End: 12/31/10 Due: 12/31/11

EAGLET: EEG vs aEEG to Improve the Diagnosis of neonataL Seizures and Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT05079971 Org: User:
Start: 07/01/23 End: 12/31/24 Due: 12/31/25

Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen.

Phase: N/A Priority: Normal
NCT ID: NCT01541852 Org: User:
Start: 06/30/12 End: 02/28/14 Due: 02/28/15

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion

Phase: N/A Priority: Normal
NCT ID: NCT04389359 Org: User:
Start: 09/30/20 End: 08/31/25 Due: 08/31/26

Comparison of Optimal Hypertension Regimens

Phase: N/A Priority: Normal
NCT ID: NCT02847338 Org: User:
Start: 11/30/16 End: 12/31/22 Due: 12/31/23

Continuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03352947 Org: User:
Start: 11/03/17 End: 11/27/20 Due: 11/27/21

Quantiative MRI and Myelin-PET for the Assessment of Degenerative Cervical Myelopathy

Phase: N/A Priority: Normal
NCT ID: NCT05242666 Org: User:
Start: 04/17/21 End: 02/01/25 Due: 02/01/26

In Vitro Models of Liver and Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02436564 Org: User:
Start: 07/31/15 End: - Due: -

Patient Agenda Setting and Clinic Efficiency in Outpatients

Phase: N/A Priority: Normal
NCT ID: NCT03433729 Org: User:
Start: 03/31/14 End: 05/31/14 Due: 05/31/15

Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT02324998 Org: User:
Start: 12/31/16 End: 05/31/19 Due: 05/31/20

Gaucherite - A Study to Stratify Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT03240653 Org: User:
Start: 01/01/14 End: 12/31/28 Due: 12/31/29

Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00563823 Org: User:
Start: 02/28/06 End: 10/31/10 Due: 10/31/11

Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study

Phase: N/A Priority: Normal
NCT ID: NCT06427694 Org: User:
Start: 06/01/24 End: 02/11/30 Due: 02/11/31

Screening Muscle Strength in Arthroscopic Surgery of the Hip

Phase: N/A Priority: Normal
NCT ID: NCT03728920 Org: User:
Start: 01/10/19 End: 12/01/19 Due: 12/01/20

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Phase: N/A Priority: Normal
NCT ID: NCT04870333 Org: User:
Start: 02/19/21 End: 04/16/25 Due: 04/16/26

Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02064608 Org: User:
Start: 10/31/14 End: 06/30/18 Due: 06/30/19

Safety of the Colonoscope Magnetic Imaging Device (ScopeGuide®) in Patients With Implantable Cardiac Devices

Phase: N/A Priority: Normal
NCT ID: NCT01825525 Org: User:
Start: 08/31/12 End: 04/30/13 Due: 04/30/14

Knee Aspiration and High Definition MRI for ACL Injury

Phase: N/A Priority: Normal
NCT ID: NCT04901858 Org: User:
Start: 11/22/19 End: 11/30/24 Due: 11/30/25

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02695966 Org: User:
Start: 05/31/15 End: 07/31/18 Due: 07/31/19